Review: taking Keppra and Claritin together


Summary

Drug interactions are reported among people who take Keppra and Claritin together. This review analyzes the effectiveness and drug interactions between Keppra and Claritin. It is created by eHealthMe based on reports of 224 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Keppra and Claritin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 20,775 users)

Claritin

Claritin has active ingredients of loratadine. It is often used in hypersensitivity. (latest outcomes from Claritin 22,301 users)

On Jul, 21, 2016

224 people who take Keppra, Claritin are studied.


Number of reports submitted per year:

Keppra and Claritin drug interactions.

Drug effectiveness over time:

Keppra:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (2 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Claritin:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 66.0% - (2 of 3 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Keppra:
  • female: 33.0% - (1 of 3 people)
  • male: 100.0% - (3 of 3 people)
Claritin:
  • female: 0.0% - (0 of 5 people)
  • male: 66.0% - (2 of 3 people)

Drug effectiveness by age:

Keppra:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 100.0% - (2 of 2 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Claritin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 66.0% - (2 of 3 people)
  • 10-19: 0.0% - (0 of 2 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • clostridium difficile sepsis
  • lymphoma
  • pneumonia
  • convulsion
  • lung neoplasm
  • pulmonary embolism
  • bradycardia
  • cardiac arrest
  • circulatory collapse
  • femur fracture
1 - 6 months:
  • femur fracture
6 - 12 months:
  • dermatitis diaper
  • drug exposure via breast milk
  • jaundice neonatal
  • maternal drugs affecting foetus
  • petechiae
  • umbilical cord around neck
  • umbilical hernia
  • weight gain poor
  • frequent bowel movements
  • naevus flammeus
1 - 2 years:
  • carnitine abnormal
  • blood prolactin increased
  • convulsion
  • galactorrhoea
  • hyperprolactinaemia
2 - 5 years:
  • constipation
  • diarrhoea
  • galactorrhoea
  • hyperprolactinaemia
  • hypervigilance
  • joint dislocation
  • convulsion
  • vomiting
  • adverse event
  • blood prolactin increased
5 - 10 years:
  • confusion
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • headache
10+ years:
  • confusion
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • headache
not specified:
  • convulsion
  • pain
  • vomiting
  • dyspnoea
  • anaemia
  • diarrhoea
  • asthenia
  • chest pain
  • mental status changes
  • urinary incontinence

Most common drug interactions by gender *:

female:
  • convulsion
  • dyspnoea
  • pain
  • chest pain
  • back pain
  • vomiting
  • anaemia
  • diabetes mellitus
  • hypertension
  • sinusitis
male:
  • convulsion
  • vomiting
  • gait disturbance
  • general physical health deterioration
  • pain
  • somnolence
  • mobility decreased
  • urinary incontinence
  • memory impairment
  • confusional state

Most common drug interactions by age *:

2-9:
  • abdominal discomfort
  • abdominal pain
  • nausea
  • post procedural haemorrhage
  • stag horn calculus
  • subdural haemorrhage
  • transaminases increased
  • vomiting
  • foetal exposure during pregnancy
  • pleural effusion
10-19:
  • convulsion
  • epilepsy
  • drooling
  • vomiting
  • drug ineffective
  • stevens-johnson syndrome
  • pulmonary embolism
  • aggression
  • angioedema
  • depressed mood
20-29:
  • convulsion
  • drug ineffective
  • sepsis
  • agitation
  • anaemia
  • blood magnesium decreased
  • pain
  • therapeutic agent toxicity
  • torsade de pointes
  • urinary tract infection
30-39:
  • nausea
  • abdominal pain upper
  • abdominal tenderness
  • angina pectoris
  • back pain
  • bradycardia
  • cardiac disorder
  • cerebrovascular accident
  • chest pain
  • cholecystitis chronic
40-49:
  • dyspnoea
  • abdominal discomfort
  • irritable bowel syndrome
  • convulsion
  • agitation
  • amnesia
  • asthenia
  • blindness
  • depression
  • gastrooesophageal reflux disease
50-59:
  • bronchitis
  • depression
  • arthralgia
  • deformity
  • dizziness
  • erythema
  • fibrosis
  • gait disturbance
  • general physical health deterioration
  • hip arthroplasty
60+:
  • convulsion
  • diarrhoea
  • deep vein thrombosis
  • death
  • mental status changes
  • pneumonia
  • anxiety
  • gastrointestinal haemorrhage
  • hiatus hernia
  • neuropathy peripheral

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Keppra and Claritin?

Can you answer these questions?

More questions for: Keppra, Claritin

You may be interested in these reviews

More reviews for: Keppra, Claritin

On eHealthMe, Keppra (levetiracetam) is often used to treat epilepsy. Claritin (loratadine) is often used to treat hypersensitivity. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.